Written testimony on the effectiveness of the individual mandate under the Affordable Care Act (ACA) to a U.S. House Ways and Means Oversight. (
)
Laurel Kastrup, chairperson of the Academy’s Health Financial Reporting and Solvency Committee, testimony at a U.S. House Subcommittee on Government Operations hearing on the federal long-term care insurance program. (
)
Written testimony on the general factors underlying premium rate setting and the major components driving premium changes for 2017 under the Affordable Care Act to a U.S. House Ways and Means Committee hearing on rising health care premiums. (
)
Academy Senior Health Fellow Cori Uccello written testimony on potential implications of expanding small-group definition to companies with 51-100 employees to a U.S. House Energy & Commerce Subcommittee on Health hearing on affordable health care. (
)
Senior Health Fellow Cori Uccello written testimony to the U.S. House Ways and Means Subcommittee on Health hearing on alternatives to the individual and employer mandates under the Affordable Care Act (ACA). (
)
Senior Health Fellow testimony to the U.S. House Oversight and Government Reform Subcommittee on Economic Growth, Job Creation, and Regulatory Affairs hearing on the Affordable Care Act's risk-sharing mechanisms, also known as the 3Rs. (
)
Senior Health Fellow written testimony to the U.S. House Oversight and Government Reform hearing on the Affordable Care Act's risk corridor program and whether it constitutes a "bailout" for insurance companies. (
)
Medicare Steering Committee testimony to the House Ways and Means Subcommittee on Health regarding the 2013 Medicare Trustees Report. (
)
Academy Senior Health Fellow Cori Uccello's written testimony to the House Energy and Commerce Subcommittee on Oversight and Investigations for a hearing on the impact of the Affordable Care Act on premiums. Responses from Uccello to follow-up questions asked during and after the hearing can be found here.
( )Academy Senior Health Fellow Cori Uccello's written testimony to the House Ways and Means Subcommittee on Health in response to its recent hearing that examined Medicare's traditional fee-for-service benefit design. (
)
 |
 |
 |
 |